Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Nasopharyngeal Carcinoma 1 Advanced Pancreatic Cancer 1

Interventions

Doxorubicin 14 pembrolizumab 11 Specimen Handling 11 Magnetic Resonance Spectroscopy 10 Cyclophosphamide 9 Biopsy 9 X-Rays 7 Radiotherapy 7 Ifosfamide 7 Phantoms, Imaging 6 Nivolumab 6 Gemcitabine 6 liposomal doxorubicin 5 Temozolomide 5 Radiation 5 tazemetostat 4 palbociclib 4 fludarabine 4 Nuclear Medicine Department, Hospital 4 Irinotecan 4 larotrectinib 3 cabozantinib 3 atezolizumab 3 Trabectedin 3 Surveys and Questionnaires 3 Radiation Dose Hypofractionation 3 Proton Therapy 3 Ipilimumab 3 Carboplatin 3 Bevacizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × penpulimab × 90 days × Clear all

NCT07612098 2026-05-28

SPARE-04

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡